Microcystic Adnexal Carcinoma
Microcystic adnexal carcinoma (MAC, also called sclerosing sweat duct carcinoma) is a malignant cutaneous adnexal neoplasm that grows quietly but is highly invasive locally. It shows dual differentiation: follicular differentiation in its superficial part and eccrine/apocrine ductal differentiation in its deeper part.
Although MAC rarely metastasizes (< 2%), its real danger lies in poorly defined deep tissue invasion and a strong tendency to track along nerves (perineural invasion, PNI), seen in 60–80% of cases.
Mutational Burden and the Role of Ultraviolet (UV) Radiation
- UV-signature mutations: Most MAC lesions arise on sun-exposed skin (the central face). Genomic analysis shows a high rate of C > T and CC > TT transitions.
- Inactivation of the TP53 and CDKN2A tumor suppressors: Loss of p53 function, together with promoter methylation or deletion of CDKN2A (p16INK4a), removes cell-cycle control and lets tumor strands invade deeply without triggering apoptosis.
- PI3K/Akt/mTOR pathway (PTEN loss): Reduced PTEN expression helps single strands of tumor cells survive as they push into dense, sclerotic collagen stroma.
Perineural Invasion (PNI) and Silent Spread
- Neurotropism: MAC cells produce neurotrophic factors (such as NGF and BDNF) that let them cling to and travel along the nerve sheaths (epineurium/perineurium).
- Subclinical spread: Tumor cells can extend several centimeters along sensory nerve branches (trigeminal nerve, CN V) or motor branches (facial nerve, CN VII), well beyond the visible edge of the lesion. This is why standard wide local excision (WLE) has failure and local recurrence rates as high as 40–60%.
Because these tumors usually sit on cosmetically sensitive sites (nose, upper lip, cheek, chin) and spread widely below the surface, Haute-Derma follows the gold standard:
- Biopsy deep enough for diagnosis: A punch biopsy or incisional biopsy must reach the deep subcutis or muscle fascia, so the tumor is not mistaken for a benign lesion based on its superficial layer.
- Complete clearance with Mohs micrographic surgery (MMS): The entire peripheral and deep margin is examined, and involved nerves are followed until the margins are completely clear of tumor (R0).
Histopathology and Immunohistochemistry (IHC)
The Characteristic Three-Layer (Triphasic) Depth Profile
Under the light microscope, MAC changes its appearance in a very characteristic way from top to bottom:
- Epidermis and superficial dermis (follicular differentiation): The overlying epidermis is usually normal or slightly thinned. The superficial dermis contains many small keratinous microcysts lined by squamous epithelium and filled with laminated keratin.
- Mid-dermis (ductal differentiation): Tumor cells form cords, nests or small tadpole-like ducts with comma-shaped tails, or double-layered ducts, embedded in a dense sclerotic stroma.
- Deep subcutis and fascia (malignant invasion and PNI): Thin, single-file strands of tumor cells tear through the subcutaneous fat, invade facial muscle, periosteum and cartilage, and wrap around or enter nerves (perineural invasion, PNI).
- Cytology: The cells are small and uniform with basophilic nuclei, very few mitoses and almost no necrosis. This bland, benign-looking cytology often misleads less experienced pathologists.
Immunohistochemical (IHC) Markers for Differential Diagnosis
| IHC Marker / Stain | Where It Is Expressed in MAC | Diagnostic Value in the Differential |
|---|---|---|
| CK7 | Cytoplasm of deep tumor cells | Strongly positive (++) – distinguishes MAC from desmoplastic basal cell carcinoma (dBCC is usually CK7–) |
| CEA / EMA | Luminal border of sweat ducts | Clearly positive (+) – confirms ductal origin (BCC and trichoepithelioma are negative) |
| Ber-EP4 | Tumor cells | Negative (0) or weak focal staining – the key distinction from dBCC (dBCC is Ber-EP4 +++) |
| CD34 | Fibrous stroma around the tumor | Loss of stromal CD34 – distinguishes MAC from desmoplastic trichoepithelioma (DTE retains stromal CD34) |
| p63 / p40 | Nuclei of epithelial tumor cells | Positive (+) – points to an adnexal epithelial origin |
| Ki-67 index | Nuclei of dividing cells | Low (< 5–15%) – reflects slow growth despite deep invasion |
High-Frequency Ultrasound and Dermoscopy Findings
High-frequency skin ultrasound:
- Shape and structure: A heterogeneous hypoechoic area, spindle-shaped or plaque-like with no clear border, that extends deep and disrupts the dermal–subcutaneous junction.
- Depth of invasion: Precisely measures how far the tumor has spread into facial muscles (such as the orbicularis oris or levator alae nasi) or the underlying periosteum.
- Dermoscopy:
- Background: A pale yellow or flesh-colored indurated plaque with loss of the normal skin markings.
- Vessels and cysts: White-yellow milium-like cysts near the surface, with fine arborizing vessels or dotted vessels.
Clinical Presentation
- Typical location: More than 80% arise on the central face, especially the nasolabial fold, upper lip, chin and periorbital area.
- Appearance: A firm, indurated plaque or a skin-colored to pale yellow papule with a blurred border. It grows extremely slowly, over 5–30 years.
- Signs of nerve involvement: Patients often report paresthesia, numbness, a burning itch or mild stabbing pain in the corresponding facial skin, caused by invasion of sensory nerve sheaths.
Multimodal Treatment at Haute-Derma
Because silent nerve invasion carries a high risk of recurrence, Haute-Derma manages MAC through a complete, end-to-end pathway:
Confirming the Diagnosis and Assessing Depth
- Biopsy of adequate depth: Must include the full thickness of the dermis and subcutaneous fat.
- Required IHC panel: CK7, Ber-EP4, CEA, EMA, CD34 and p63 to rule out desmoplastic basal cell carcinoma (dBCC) and desmoplastic trichoepithelioma.
- Head and neck MRI: Ordered when there are nerve symptoms (numbness, paresthesia) or when ultrasound suggests invasion of the jawbone or infraorbital groove.
Mohs Surgery (Mohs Micrographic Surgery, MMS) — The Gold Standard
- Complete margin assessment: Tissue is removed layer by layer, and the entire peripheral and deep margin is examined on frozen sections during the operation.
- Managing perineural invasion (PNI): The Mohs surgeon follows tumor strands along the nerve sheath until the final section is free of tumor. This is the most effective way to cut MAC's local recurrence rate from more than 50% to under 5%.
Cosmetic Reconstruction and Long-Term Follow-Up
- Reconstruction with complex flaps: Once clear R0 margins are achieved, the defect is repaired with advanced local flaps, combined with exosome/PDRN treatment, to restore the face's natural contours.
- Adjuvant radiotherapy: Considered when nerve involvement is too extensive to clear microscopically, or when the patient cannot undergo further surgery.
- Long-term follow-up: Because MAC can recur late, after 5–10 years, patients should be seen every 3–6 months for the first 5 years and then every 12 months up to year 10.
